stars 1 stars 2 stars 3

Univercell-Biosolutions® is pleased to introduce its Center of expertise dedicated to human induced pluripotent stem cells (hiPSC) production. Univercell-Biosolutions works with clinicians, academics and industry leaders to produce next-generation hiPSc. Our team developed a panel of innovative and efficient quality controls to provide our customers with well characterized and standardized high quality hiPSc. Our goals are to make collaborations with relevant and robust hiPS tailored to fit with most differentiation protocols, to be efficient in the discovery of new therapeutics and to reduce the drug failure rate in clinical trials. For the first time, the end users applications and bottlenecks led our hIPSC cell lines development. As each application is particular we have designed processes to fit the different culture systems and to integrate the differentiation potential of iPSC. Our main expertise include: • Management, qualification and fibroblasts validation • Human sample management and banking • Fibroblasts reprogramming • hiPSc qualification and stabilization • Industrial hiPSc production following a standardized process • Pluripotency validation • hiPSc banking You may take advantage of our Centre of expertise through: 1. Pluri-one® Custom: Univercell-Biosolutions reprograms specialized iPSCs from human samples provided by the client. 2. Population of patients’ identification and sampling: Univercell-Biosolutions has access to samples of specific populations of patients displaying specific familial conditions. 3. Services: Our services include cell reprogramming, production, validation, banking services and management, fibroblasts validation 4. Technology transfer: We assist in the implementation of an in-house platform and provide staff training and stabilization of differentiation protocols where necessary. For more information please visit us on www.univercell-biosolutions.com or contact us on contact@univercell-biosolutions.com

Univercell-Biosolutions Questions

The Univercell-Biosolutions annual revenue was $5 million in 2026.

1 people are employed at Univercell-Biosolutions.

Univercell-Biosolutions is based in Toulouse, Occitania.

The NAICS codes for Univercell-Biosolutions are [541, 54, 541713, 5417, 54171].

The SIC codes for Univercell-Biosolutions are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users